Newsletters – Term Sheet – IPOs
Fortune
September 17, 2021
“Immix Biopharma, a Los Angeles-based oncology drug company, filed for an initial public offering …”
11400 West Olympic Blvd, Suite 200
Los Angeles, CA 90064
T: (310) 651 8041
© 2021 Immix Biopharma, Inc.
Los Angeles, CA 90064
T: (310) 651 8041
© 2021 Immix Biopharma, Inc.
Collaboration:
Scientific Advisory Board Member Institutions:
Comments are closed